Table 17 Anti-inflammatory screening results
From: Pharmacological significance of heterocyclic 1H-benzimidazole scaffolds: a review
Comp. | Paw oedema thickness (mm) | |||
|---|---|---|---|---|
30 m (X ± SE) | Oedema Inhibition (%) | 60 m (X ± SE) | Oedema Inhibition (%) | |
Control | 1.3 ± 0.05 | – | 1.5 ± 0.03 | – |
17a | 1.1 ± 0.03 | 15.3 | 1.1 ± 0.00 | 26.6 |
17b | 1.2 ± 0.03 | 7.6 | 1.1 ± 0.06 | 26.6 |
Nimesulide | 1.1 ± 0.05 | 15.3 | 1.1 ± 0.00 | 26.6 |